Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

Relationship between toxicities and clinical benefits of newly approved tyrosine kinase inhibitors in thyroid cancer: A meta-analysis of literature

Ye Xiaobing, Zhu Yiping, Cai Juan

Year : 2015| Volume: 11| Issue : 6 | Page no: 185-190

   This article has been cited by
 
1 Audit of Demographics, Treatment Patterns and Outcomes of Differentiated Thyroid Cancers Treated with Tyrosine Kinase Inhibitors
Amit Kumar Choudhary, George Abraham, Vijay Maruti Patil, Nandini Menon, Tanmoy Mandal, Sobin Jacob, Keshav Garg, Anbarasan Sekar, Rup Jyoti Sarma, Laxma Reddy, Dipti Nakti, Neha Mittal, Munita Bal, Swapnil Rane, Nilendu Purandare, Abhishek Mahajan, Nilesh Sable, Suman Kumar, Vanita Noronha, Kumar Prabhash
Indian Journal of Surgical Oncology. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Usefulness of CyberKnife Therapy in Patients with Differentiated Thyroid Cancer with Distant Metastases
Atsushi Yoshida, Shigeaki Higashiyama, Yutaka Katayama, Takashi Yamanaga, Joji Kawabe
An International Journal of Otorhinolaryngology Clinics. 2021; 12(2): 38
[Pubmed]  [Google Scholar] [DOI]
3 Bronchial artery aneurysms arising from antiangiogenic therapy
Miguel Borregón Rivilla, Katherin Aly Martínez Barroso, Elia Martínez Moreno, Alba María Ramos Garrido, Irene Ramos Reguera, Manuel Alejandro Mazariegos Rubí, Beatríz Berzal Hernández, Aitana Palomares Morales, Celia Ástor Rodríguez, Ruth Álvarez Cabellos
Current Problems in Cancer. 2020; 44(6): 100569
[Pubmed]  [Google Scholar] [DOI]
4 Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation
Nigel Fleeman, Rachel Houten, Adrian Bagust, Marty Richardson, Sophie Beale, Angela Boland, Yenal Dundar, Janette Greenhalgh, Juliet Hounsome, Rui Duarte, Aditya Shenoy
Health Technology Assessment. 2020; 24(2): 1
[Pubmed]  [Google Scholar] [DOI]
5 Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer
Kenji Makita, Yasushi Hamamoto, Shintaro Tsuruoka, Noriko Takata, Yusuke Urashima, Masao Miyagawa, Teruhito Mochizuki
International Journal of Clinical Oncology. 2020; 25(4): 691
[Pubmed]  [Google Scholar] [DOI]
6 Two thyroid cancer patients who received lenvatinib
Mioko Matsuo
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY. 2016; 26(2): 259
[Pubmed]  [Google Scholar] [DOI]

 

Read this article